Published in Cancer Weekly, October 21st, 2003
The award, the highest scientific honor given by the society, lauds Witte for his lifetime achievement in cancer research and recognizes his significant contributions to understanding the cause of certain blood cancers and immune disorders - findings that have led to the development of improved therapies for patients.
Specifically, Witte's research has been instrumental in the evolution of the molecularly targeted therapy,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.